US Patent Issued to KURUME UNIVERSITY on May 19 for "Use of microRNA as pancreatic cancer biomarker" (Japanese Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,881, issued on May 19, was assigned to KURUME UNIVERSITY (Fukuoka, Japan).

"Use of microRNA as pancreatic cancer biomarker" was invented by Takahiko Sakaue (Kurume, Japan), Hideki Iwamoto (Kurume, Japan), Hironori Koga (Kurume, Japan), Yoshinobu Okabe (Kurume, Japan) and Takuji Torimura (Kurume, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Use of at least one microRNA comprising a nucleotide sequence set forth in any of SEQ ID NOS: 1 to 15 in a biological sample derived from a subject as a pancreatic cancer biomarker, wherein the pancreatic cancer biomarker is for determining whether the subject suffers from pancreatic cancer, for determining...